[患者内癌症异质性和萨基图祖马布-戈维特康的疗效.]
Andrea Fontana1, Federica Pantaleo1
1UO Oncologia universitaria, Azienda Ospedaliero-Universitaria Pisana, Pisa.
Recenti progressi in medicina
|October 24, 2024
概括
萨西图祖马布戈维特康对晚期三阴性乳腺癌 (TNBC) 是有前途的. 转移性病变的再活检对于TNBC患者来说至关重要,以重新评估瘤特征并指导治疗.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 先进的三阴性乳腺癌 (TNBC) 提出了重大的治疗挑战.
- 对于转移性TNBC患者,存在有限的治疗选择.
研究的目的:
- 报告在转移阶段诊断的TNBC病例.
- 突出重复活检对TNBC转移性病变的重要性.
主要方法:
- 一个患有转移性TNBC的患者的病例报告.
- 对瘤特征的审查,包括ER和PgR表达.
- 讨论乳腺癌演变中的瘤异质性.
主要成果:
- 患者的原发性瘤显示了雌激素受体 (ER) 和孕激素受体 (PgR) 的过度表达.
- 发现了瘤异质性,强调了重新活检的必要性.
结论:
- 萨西图祖马布 (govitecan) 在高级TNBC中显示出临床疗效.
- 转移性病变再活检对于TNBC的准确表征和最佳治疗策略至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K